91¹ú²ú¾«Æ·

Artificial Intelligence in Hematology: From Generative AI to Ethics and Applications

The session will address important and timely topics related to the application of artificial intelligence (AI) to hematology, ranging from generative AI's potential and pitfalls, modern ethical consideration for AI in biomedical research and examples of practical use of AI in hematology research and clinical care.

Chair:

°¿±ô¾±±¹¾±±ð°ùÌý·¡±ô±ð³¾±ð²Ô³Ù´Ç,Ìý±Ê³ó¶Ù,²Ñ³§,µþ³§
Weill Cornell Medicine
New York,ÌýNY

Speakers:

´³²¹³¾±ð²õÌý´Ü´Ç³Ü,Ìý±Ê³ó¶Ù
Stanford University
³§³Ù²¹²Ô´Ú´Ç°ù»å,Ìý°ä´¡
The Potential and Pitfalls of Generative AI in Basic and Clinical Research

CamilleÌýNebeker,ÌýEdD, MS
University of California San Diego
San Diego,ÌýCA
From Principles to Practice: Ensuring Ethical Integrity in AI-Driven Biomedical Research

°ä±ô²¹³Ü»å¾±²¹Ìý±á²¹´Ú±ð°ù±ô²¹³¦³ó,Ìý²Ñ¶Ù
MLL Munich Leukemia Laboratory
²Ñ³Ü²Ô¾±³¦³ó,Ìý³Ò±ð°ù³¾²¹²Ô²â
The Application of Artificial Intelligence in Hematological Diagnostics

back to top

ASH Clinical Practice Guidelines on Acute Lymphoblastic Leukemia (ALL) in Adolescents and Young Adults

This session will preview recommendations for initial therapy and management of remission and relapse in adolescents and young adults with ALL.

Chair:

SumitÌýGupta,ÌýMD, PhD
Hospital for Sick Children
°Õ´Ç°ù´Ç²Ô³Ù´Ç,Ìý°¿±·,Ìý°ä²¹²Ô²¹»å²¹

Speakers:

JulieÌýWolfson,ÌýMD, MSHS
The University of Alabama at Birmingham
µþ¾±°ù³¾¾±²Ô²µ³ó²¹³¾,Ìý´¡³¢
Management of Frontline ALL in AYA

Jennifer L.ÌýMcNeer,ÌýMD
University of Chicago
°ä³ó¾±³¦²¹²µ´Ç,Ìý±õ³¢
Management of Frontline ALL in AYA

Kristen M.ÌýO'Dwyer,ÌýMD
University of Rochester
¸é´Ç³¦³ó±ð²õ³Ù±ð°ù,Ìý±·³Û
Management of Refractory and Relapse of ALL in Adolescents and Young Adults

Lena EÌýWinestone,ÌýMD
University of California San Francisco
San Francisco,ÌýCA
Management of Refractory and Relapse of ALL in Adolescents and Young Adults

back to top

ASH Clinical Practice Guidelines on Amyloidosis

This session will review the scope and goals of the upcoming guidelines on amyloidosis, and will provide insights on risk factors, selecting a target site versus a surrogate site for diagnostic biopsies, and using Congo Red stain screening.

Chair:

³Õ¾±²õ³ó²¹±ôÌý°­³Ü°ì°ù±ð³Ù¾±
University Health Network
°Õ´Ç°ù´Ç²Ô³Ù´Ç,Ìý°¿±·,Ìý°ä²¹²Ô²¹»å²¹

Speakers:

´³´Ç²õ±ð±ô±ô±ðÌý°ä´Ç´Ç°ì,Ìý²Ñµþµþ³§
Mayo
¸é´Ç³¦³ó±ð²õ³Ù±ð°ù,Ìý²Ñ±·
Increasing Awareness of Risk Factors for AL Amyloidosis

´¡²Ô²µ±ð±ô²¹Ìý¶Ù¾±²õ±è±ð²Ô³ú¾±±ð°ù¾±,Ìý²Ñ¶Ù
Mayo Clinic
¸é´Ç³¦³ó±ð²õ³Ù±ð°ù,Ìý²Ñ±·
Target Site vs. Surrogate Site Biopsy for Diagnosis

±á¾±°ù²¹Ìý³§³ó²¹¾±°ì³ó,Ìý²Ñ¶Ù
University of Iowa Caver College of Medicine
°ä´Ç°ù²¹±ô±¹¾±±ô±ô±ð,Ìý±õ´¡
Target Site Vs. Surrogate Site Biopsy for Diagnosis

±·²¹°ù±ð²õ³óÌýµþ³Ü³¾³¾²¹,Ìý²Ñ¶Ù
The Ohio State University
°ä´Ç±ô³Ü³¾²ú³Ü²õ,Ìý°¿±á
Congo Red Stain Bone Marrow Screening for AL Amyloidosis

back to top

ASH Clinical Practice Guidelines on Pediatric Venous Thromboembolism (VTE)

This session will highlight new and revised recommendations for the treatment of VTE in pediatric patients, including addressing asymptomatic VTE, duration of therapy for provoked and unprovoked VTE, and use of anticoagulants.

Chair:

±Ê²¹³Ü±ôÌý²Ñ´Ç²Ô²¹²µ±ô±ð,Ìý²Ñ¶Ù,µþ³§,²Ñ³§³¦,¹ó¸é´¡°ä±Ê,¹ó¸é°ä±Ê´¡,²Ñµþ
University of Melbourne Royal Children's Hospital
±Ê²¹°ù°ì±¹¾±±ô±ô±ð,Ìý³Õ±õ°ä,Ìý´¡³Ü²õ³Ù°ù²¹±ô¾±²¹

Speakers:

³¢±ð²õ±ô¾±±ðÌý¸é²¹´Ú´Ú¾±²Ô¾±,Ìý²Ñ¶Ù
Children's Hospital of Philadelphia
±Ê³ó¾±±ô²¹»å±ð±ô±è³ó¾±²¹,Ìý±Ê´¡
Why Revise the Guidelines?

¸é³Ü°ì³ó³¾¾±Ìýµþ³ó²¹³Ù,Ìý²Ñ¶Ù,²Ñ³§
Lurie Children's Hospital
°ä³ó¾±³¦²¹²µ´Ç,Ìý±õ³¢
Asymptomatic VTE in Pediatric Patients

²Ñ²¹°ù¾±²õ´Ç±ôÌýµþ±ð³Ù±ð²Ô²õ°ì²â,Ìý²Ñ¶Ù
Johns Hopkins All Children's Hospital
Saint Petersburg,ÌýFL
Duration of Therapy for Provoked and Unprovoked VTE in Pediatric Patients

°Õ¾±²Ô²¹Ìýµþ¾±²õ²õ
The Newcastle upon Tyne Hospitals NHS Trust
Newcastle Upon Tyne,ÌýENG,ÌýUnited Kingdom
Use of Anticoagulants in Children

back to top

ASH Clinicians in Practice (ACIP) Lunch - The Role of Artificial Intelligence in Hematology Practice: The Good, the Bad, and the Ugly

Artificial Intelligence (AI) has the potential to transform health care by enhancing diagnostic accuracy, predicting patient outcomes, and developing personalized treatment plans. Machine learning algorithms can analyze vast amounts of medical data, leading to more efficient and precise health care interventions, which could improve patient care and reduce costs. However, implementation of AI in health care also poses challenges related to data privacy concerns, ethical considerations, and the need for robust regulatory frameworks to ensure the responsible and secure use of sensitive medical information. In this session, panelists will speak on the recent advances and use of AI in health care, how it’s integrated into hematology practice by providers, and the use of AI by patients.

Chair:

Mary-Elizabeth M.ÌýPercival,ÌýMD
Seattle Cancer Care Alliance
³§±ð²¹³Ù³Ù±ô±ð,Ìý°Â´¡

Speakers:

´³¾±³¾Ìý°Â³ó¾±³Ù´Ú¾±±ô±ô
Honor Health
±Ê³ó´Ç±ð²Ô¾±³æ,Ìý´¡´Ü
Artificial Intelligence in Health Care: Benefits and Pitfalls

ChristopherÌýManz,ÌýMD, MSHP
Dana-Farber Cancer Institute
µþ´Ç²õ³Ù´Ç²Ô,Ìý²Ñ´¡
Artificial Intelligence as a Clinical Tool: Hacks in Practice

Gwen LÌýNichols,ÌýMD
The Leukemia and Lymphoma Society
Rye Brook,ÌýNY
Patient Facing Artificial Intelligence: Uses and Ethical Implications

back to top

ASH Quality Improvement Champions

This new session merges the ASH Choosing Wisely Champions and the ASH Guideline Implementation Champions into a single, 90-minute session. Speakers will be selected from a pool of applicants. In addition to projects that combat overuse (previously the focus of the Choosing Wisely Champions session) and projects that highlight successful guideline implementation strategies (previously the focus of the Guideline Implementation Champions session), the call for applications for this session considers any quality improvement project (e.g., combating underuse, improving stewardship of resources, improving processes, reducing or eliminating healthcare disparities, etc.). The goal of this change is to expand opportunities to highlight high-quality quality improvement work while concentrating the focus into a single session.

Co-Chairs:

Ming Y Y.ÌýLim,ÌýMBBChir
University of Utah Health
Salt Lake Cty,ÌýUT

Rachel P.ÌýRosovsky,ÌýMD
Massachusetts General Hospital
µþ´Ç²õ³Ù´Ç²Ô,Ìý²Ñ´¡

Speakers:

JosieÌýFernandez Sanchez,ÌýMD
Texas Children’s Hospital, Baylor College of Medicine
±á´Ç³Ü²õ³Ù´Ç²Ô,Ìý°Õ³Ý
Standardizing Emergency Department Management of Iron Deficiency Anemia from Heavy Menstrual Bleeding

±Ê²¹´Ç±ô´ÇÌý³¢´Ç±è±ð»å´Ç³Ù±ð,Ìý²Ñ¶Ù
City of Hope National Medical Center
²Ñ´Ç²Ô°ù´Ç±¹¾±²¹,Ìý°ä´¡
Reduced Blood Transfusions in Patients with Chronic Liver Disease Undergoing Paracentesis

Asinamai MÌýNdai,ÌýBPharm, MS
University of Florida Health Physicians
³Ò²¹¾±²Ô±ð²õ±¹¾±±ô±ô±ð,Ìý¹ó³¢
Optimized Management of Hemophilia in the Emergency Department

back to top

91¹ú²ú¾«Æ· Collaborative Data Hub Sickle Cell Disease Network: Accelerating Research and Collaborative Clinical Care through Real-World Evidence Generation

Session Description: During this 90-minute special-interest session, sickle cell disease (SCD) registry and real-world evidence (RWE) leaders will discuss progress across numerous SCD data initiatives, including the 91¹ú²ú¾«Æ· Collaborative’s SCD Data Hub and other federal and non-federal programs. Specific topics include examples of using real-world data (RWD) to generate RWE, how RWD can be used to monitor clinical practice and outcomes for patients who receive cell and gene therapies, various approaches to ensuring data quality when using electronic health record data (EHR), federal priorities related to RWE generation that supports regulated research, and a new project to increased SCD-specific data standards within EHRs.ÌýÌýÌý

Co-Chairs:

AlexisÌýThompson,ÌýMD, MPH
Perelman School of Medicine, University of Pennsylvania
±Ê³ó¾±±ô²¹»å±ð±ô±è³ó¾±²¹,Ìý±Ê´¡

TedÌýWun,ÌýMD
Center for Oncology Hematology Outcomes Research and Training (COHORT), Division of Hematology and Oncology, University of California Davis Comprehensive Cancer Center
Sacramento,ÌýCA

Speakers:

AlexisÌýThompson,ÌýMD, MPH
Children's Hospital of Philadelphia
±Ê³ó¾±±ô²¹»å±ð±ô±è³ó¾±²¹,Ìý±Ê´¡
Representing Sickle Cell Disease Health Concepts in Real World Evidence Generation: Examples from Real World Data (RWD) Initiatives and the Importance to the Sickle Cell Disease Community

PattyÌýSteinert,ÌýPhD,MBA
Medical College of Wisconsin
Milwaukee,ÌýWI
The Role of RWD in Long-Term Follow-up of Cell and Gene Therapies in Sickle Cell Disease: The CIBMTR experience

SophieÌýLanzkron,ÌýMD
Thomas Jefferson University
Baltimore,ÌýMD
Challenges in Data Quality: Where EHR Data Acquisition Approaches and Highly-Curated Datasets Intersect (1)

AshimaÌýSingh,ÌýPhD,MS
Medical College of Wisconsin
Pewaukee,ÌýWI
Challenges in Data Quality: Where EHR Data Acquisition Approaches and Highly-Curated Datasets Intersect (2)

NicoleÌýVerdun,ÌýMD
FDA
Silver Spring,ÌýMD
Regulatory Perspective: Why RWD is Critical for Evaluation of SCD Disease Modifying Curative Therapies

LaVerneÌýPerlie,ÌýMSN, BSN, RN
Health and Human Services
Washington,ÌýDC
Bringing It All Together: How the Federal Government Is Facilitating Collaboration across the Sickle Cell Data Landscape

back to top

91¹ú²ú¾«Æ· Collaborative Multiple Myeloma Network: Accelerating Research and Collaborative Clinical Care through Real-World Evidence Generation

This 90-minute special-interest session will focus on the 91¹ú²ú¾«Æ· Collaborative’s Multiple Myeloma Program’s efforts to accelerate research and collaborative clinical care in hematologic malignancies. Three topics will describe the 91¹ú²ú¾«Æ· Collaborative’s approach to aggregating and visualizing real-world data (RWD) in multiple myeloma in a US-based, multi-site network; a proof-of-concept study with a hybrid decentralized workflow that was conducted in the ASH RC Myeloma Network this year; and new directions for RWD analysis in hematologic malignancies, including the use of artificial intelligence. A panel will then highlight work that is being done by the European HARMONY Alliance and other real-world data registries.

Chair:

Kenneth C.ÌýAnderson,ÌýMD
Dana-Farber Cancer Institute
µþ´Ç²õ³Ù´Ç²Ô,Ìý²Ñ´¡

Speakers:

William A.ÌýWood,ÌýMD,MPH
University of North Carolina At Chapel Hill Hospital
Chapel Hill,ÌýNC
Building a National Multiple Myeloma Data Hub to Accelerate Research and Enhance Clinical Care

Saad Z.ÌýUsmani,ÌýMD
Memorial Sloan Kettering Cancer Center
New York,ÌýNY
Working with Data Hub Data and Network PIs to Develop Evidence that Changes Practice in Multiple Myeloma: The COSMIC Study as Proof of Concept

ShajiÌýKumar,ÌýMD
Mayo Clinic
¸é´Ç³¦³ó±ð²õ³Ù±ð°ù,Ìý²Ñ±·
Pushing Data Frontiers: How Artificial Intelligence and Molecular Data can Facilitate Translational Research in the Network

Jesus MariaÌýHernandez Rivas,ÌýMD
University of Salamanca, IBSAL, IBMCC, CSIC
Salamanca,ÌýSpain
Panel Discussion: Real World Experience with Establishing Registries and Reporting Results (Panelist 1)

ElenaÌýZamagni,ÌýMD
Bologna University School of Medicine
Bologna,ÌýItaly
Panel Discussion: Real World Experience with Establishing Registries and Reporting Results (Panelist 2)

Doris K.ÌýHansen,ÌýMD
H. Lee Moffitt Cancer Center and Research Institute
Tampa,ÌýFL
Panel Discussion: Real World Experience with Establishing Registries and Reporting Results (Panelist 3)

back to top

Blood Advances Presents: How to Peer Review a Scientific Paper

Peer review plays a vital role in the dissemination and assessment of scientific research. Authors benefit from receiving an independent assessment of their work and reviewers benefit by gaining access to novel data. Dr. Catherine Bollard and Dr. Andrew Weyrich, the editor-in-chief and deputy editor for Blood Advances, will present recommended practices for reviewing a scientific paper for a peer-reviewed journal. The session will include topics such as things to consider when accepting or declining an invitation to review, how to write a review that is helpful for authors and editors, and what a reviewer should do if they suspect a possible research integrity issue. The presentation will be followed by a period for audience questions.

Panelists:

Catherine M.ÌýBollard,ÌýMD
Children's National Hospital and The George Washington University
Washington,ÌýDC

Andrew S.ÌýWeyrich,ÌýPhD
Oklahoma Medical Research Foundation
Oklahoma City,ÌýOK

back to top

Blood Presents: How to Get Published in a Peer-Reviewed Journal

Peer-reviewed journals serve a crucial role in helping researchers refine and publicize their work and helping readers sort through the ever-expanding scientific literature. Yet finding the right journal for one's research and framing data properly can be a challenge. Dr. Nancy Berliner and Dr. Andrew Roberts, the editor-in-chief and deputy editor for Blood, will present recommended practices for writing a scientific paper and submitting it to a peer-reviewed journal. The session will include topics such as how to develop the "story" for your research, how to respond to reviewer comments, and what to do when your submission is rejected. The presentation will be followed by a period for audience questions.

Panelists:

NancyÌýBerliner,ÌýMD
Brigham and Women's Hospital
µþ´Ç²õ³Ù´Ç²Ô,Ìý²Ñ´¡

Andrew W.ÌýRoberts,ÌýMBBS,PhD
The Walter and Eliza Hall Institute of Medical Research
±Ê²¹°ù°ì±¹¾±±ô±ô±ð,Ìý³Õ±õ°ä,Ìý´¡³Ü²õ³Ù°ù²¹±ô¾±²¹

back to top

Center for Sickle Cell Disease Initiatives: Advancing Progress in Sickle Cell Disease Update and Reception: hosted by ASH and 91¹ú²ú¾«Æ· Collaborative

All meeting attendees interested in sickle cell disease are invited to attend the Center for Sickle Cell Disease Initiatives: Advancing Progress in Sickle Cell Disease Update and Reception. ASH is continuing its keen focus on the sickle cell disease initiative through the newly established ASH Center for Sickle Cell Disease Initiatives. This new Center will bring greater focus and cohesion to advancing our SCD initiatives. The Center is enhancing our ability to coordinate, track, and manage the wide range of responsibilities for this strategic initiative. The Center is focused on: Convening multidisciplinary partners and collaborators, promoting access to high quality care, global issues, policy and advocacy, research, and leveraging data. Please join us for an evening of networking and learn about this year's accomplishments.

back to top

DEI Community Networking Lunch (for in-person participants)

This is a community-building and networking event for members that fall within the diversity, equity, and inclusion (DEI) umbrella to gather and get to know each other across the varying and intersectional communities. This event is hosted by the Committee on Diversity, Equity, and Inclusion and aims to create space for ASH DEI communities and allies and, where possible, identify opportunities to learn more about the experiences and needs of these communities to allow ASH to have a greater impact in its DEI efforts. This year’s event will include inspiring remarks from a member of the committee and networking opportunities throughout.

Moderators:

NohaÌýSoror,ÌýMD,MSc
University of Oklahoma Health Science Center
Edmond,ÌýOK

SarwishÌýRafiq,ÌýPh.D.
Emory University School of Medicine
Atlanta,ÌýGA

Panelist:

MarcosÌýde Lima,ÌýMD
The Ohio State University
°ä´Ç±ô³Ü³¾²ú³Ü²õ,Ìý°¿±á

back to top

Early Faculty Career Development Session

In this Junior Faculty Career Development Session, attendees will hear a series of lectures focused on Mentorship. These didactic lectures will feature mentoring experts sharing their experiences in how to receive, provide, and optimize mentoring. Mentor/Mentee relationships can be hard to foster, and in this session, we will focus on empowering junior faculty with the tools to get the most out of this relationship. Junior faculty will hear from mentors and mentees both in the clinical and basic research fields and gain a better understanding on what it is to be a good mentor and mentee.

Co-Chairs:

Adam ScottÌýKittai,ÌýMD
The Ohio State University
°ä´Ç±ô³Ü³¾²ú³Ü²õ,Ìý°¿±á

Andrew GÌýVolk,ÌýPhD
Cincinnati Children's Hospital Medical Center
Cincinnati,ÌýOH

Speakers:

Betty S.ÌýPace,ÌýMD
Augusta University
Augusta,ÌýGA
Identifying a Mentor and Optimizing the Mentor/Mentee Relationship, How to be a Good Mentee?

Adam ScottÌýKittai,ÌýMD
The Ohio State University
°ä´Ç±ô³Ü³¾²ú³Ü²õ,Ìý°¿±á
Identifying a Mentor and Optimizing the Mentor/Mentee Relationship, How to be a Good Mentee?

JosephÌýMikhael,ÌýMD, MeD, FRCPC, FACP
Translational Genomics Research Institute
±Ê³ó´Ç±ð²Ô¾±³æ,Ìý´¡´Ü
The Warning Signs of a Problematic Mentoring Relationship and How to Fix it

ShannonÌýElf,ÌýPhD
The University of Chicago
°ä³ó¾±³¦²¹²µ´Ç,Ìý±õ³¢
The Warning Signs of a Problematic Mentoring Relationship and How to Fix it

LeidyÌýIsenalumhe
Moffitt Cancer Center
Lutz,ÌýFL
Transitioning from Being a Mentee to Becoming a Mentor

RaquelÌýEspin Palazon,ÌýPhD
Iowa State University
Ames,ÌýIA
Transitioning from Being a Mentee to Becoming a Mentor

back to top

Grassroots Network Lunch

The ASH Grassroots Network Lunch provides a forum for interested members to learn how they can participate in ASH’s advocacy efforts, communicate with Congress and their elected officials, become effective advocates for hematology, and discuss the Society’s legislative and regulatory priorities. An overview of the Society’s 2024 advocacy accomplishments and a preview of the Society’s 2025 advocacy agenda will also be provided.

Co-Chairs:

JenniferÌýHolter-Chakrabarty,ÌýMD
University of Oklahoma Stephenson Cancer Center
Oklahoma City,ÌýOK

Bart L.ÌýScott,ÌýMD
Fred Hutchinson Cancer Center
³§±ð²¹³Ù³Ù±ô±ð,Ìý°Â´¡

Speaker:

KirkÌýBado
National Journal
Washington,ÌýDC
Grassroots Network Lunch

back to top

Health Equity Rounds Lunch

Health Equity Rounds are interactive, case-based discussions with an interdisciplinary panel to include hematologists, health equity/public health experts, patients, and patient advocates to discuss health equity issues within hematology. Lunch will be provided to in-person attendees.

Co-Chairs:

Yvonne A.ÌýEfebera,ÌýMD
Ohio Health
°ä´Ç±ô³Ü³¾²ú³Ü²õ,Ìý°¿±á

SrinivasÌýDevarakonda,ÌýMD
Ohio State University Medical Center
°ä´Ç±ô³Ü³¾²ú³Ü²õ,Ìý°¿±á

Speakers:

Ash BlytheÌýAlpert,ÌýMD, MFA
Yale School of Medicine
New Haven,ÌýCT
Hematologic Aspects of Gender Affirming Care

Eric ScottÌýMullins,ÌýMD
Cincinnati Children's Hospital Medical Center
Cincinnati,ÌýOH
Hematologic Aspects of Gender Affirming Care

back to top

Health Equity Symposium: Race, Structural Racism and the Social Determinants of Health in Hematology

The misuse of race in medicine has far-reaching implications across practice, teaching, and research in hematology. This session is intended to explore what race is and what it is not, and illustrate how systemic factors, including racism, influence health care access and outcomes. The session will also explore strategies to tackle systemic racism in patient care and how to create conditions for equitable care for patients with blood diseases. Dr. Joseph L. Graves Jr. will provide a summary of the history of biological conceptions of race and describe modern evolutionary conceptions of race. He will then address how this understanding can be useful in employing the power of modern genomic tools applied to human biological diversity, including how the use of these tools completely unravels the false premises of racial medicine. Dr. Chanita Hughes Halbert will define health care disparities and describe the nature and distribution of social determinants of disparities in disease risk and outcomes. She will also provide an overview of structural racism and its impact on health care outcomes in diverse populations.

Chair:

Deirdra RÌýTerrell,ÌýPhD
University of Oklahoma Health Sciences Center
Oklahoma City,ÌýOK

Speakers:

Joseph LÌýGraves Jr.,ÌýPhD
North Carolina A&T State University
Greensboro,ÌýNC
The Myth of Race in Medical Science

Chanita HughesÌýHalbert,ÌýPhD
University of Southern California
Los Angeles,ÌýCA
Structural Racism, the Social Determinants of Health, and Healthcare Outcomes – Understanding Inequity and What to Do About It

back to top

Hematology Inclusive Pathway (HIP) Networking Reception

Join our HIP community to network and celebrate our awardees and their mentors at this reception following the oral presentations.Ìý

back to top

Hematology Inclusive Pathway (HIP) Oral Presentations: Room I (Malignant Hematology)

The Hematology Inclusive Pathway Presentations and Reception (previously known as Promoting Minorities in Hematology); ASH invites all interested meeting attendees to this event, which will showcase the research of our Hematology Inclusion Pathway awardees. This initiative is a comprehensive 13-year longitudinal career pathway of awards that strives to ensure that hematology reflects and serves the diverse world we live in. The highlight of the session will be oral scientific presentations from program participants.

back to top

Hematology Inclusive Pathway (HIP) Oral Presentations: Room II (Health Services Outcomes)

The Hematology Inclusive Pathway Presentations and Reception (previously known as Promoting Minorities in Hematology); ASH invites all interested meeting attendees to this event, which will showcase the research of our Hematology Inclusion Pathway awardees. This initiative is a comprehensive 13-year longitudinal career pathway of awards that strives to ensure that hematology reflects and serves the diverse world we live in. The highlight of the session will be oral scientific presentations from program participants.Ìý

back to top

Hematology Inclusive Pathway (HIP) Oral Presentations: Room III (Classical Hematology)

The Hematology Inclusive Pathway Presentations and Reception (previously known as Promoting Minorities in Hematology); ASH invites all interested meeting attendees to this event, which will showcase the research of our Hematology Inclusion Pathway awardees. This initiative is a comprehensive 13-year longitudinal career pathway of awards that strives to ensure that hematology reflects and serves the diverse world we live in. The highlight of the session will be oral scientific presentations from program participants.Ìý

back to top

LGBTQIA+ Community Networking Brunch (for in-person participants)

This is a community-building and networking event for members of the LGBTQIA+ community attending the meeting. The event is hosted by the Committee on Diversity, Equity, and Inclusion and aims to create a sense of belonging and allyship. This year’s event will include an insightful panel discussion focused on being LGBTQIA+ across the hematology career spectrum, including the role of mentorship and the importance of inclusivity, as well as ample networking opportunities.

Moderator:

JonasÌýJutzi,ÌýMD, PhD
Brigham and Women’s Hospital, Harvard Medical School
Boston,Ìý

Panelists:

Mouhamed YazanÌýAbou-Ismail,ÌýMD
University of Utah
Salt Lake City,ÌýUT

Ash BlytheÌýAlpert,ÌýMD, MFA
Yale School of Medicine
New Haven,ÌýCT

DianeÌýKrause
Yale University
New Haven,ÌýCT

back to top

Medical Educators Symposium

The Medical Educators Symposium (previously called the Hematology Course Directors Workshop) is open to all medical educators across the medical student, resident, and fellow continuum. The Medical Educators Symposium highlights cutting edge teaching techniques and theories while also showcasing participants of the ASH Medical Educators Institute. The symposium is two hours long and will begin with an hour of general sessions focused on medical education principles and then followed by simultaneous breakout sessions that happen twice.

Chair:

Hetty E.ÌýCarraway,ÌýMD,MBA
Cleveland Clinic
Cleveland,ÌýOH

Speakers:

AlisonÌýLoren,ÌýMD
University of Pennsylvania
±Ê³ó¾±±ô²¹»å±ð±ô±è³ó¾±²¹,Ìý±Ê´¡
General Session 1: Paving a Career in Medical Education & Scholarship

Megan MurrayÌýDupuis,ÌýMD, PhD
Vanderbilt University Medical Center
Nashville,ÌýTN
General Session 2: Utilizing Humanities to Influence and Tailor Hematology Curriculum for Adult Learners

LaylaÌýVan Doren
Yale University
New York,ÌýNY
General Session 3: Incorporating Health Equity Education in UME/GME Curriculum

Alexander AÌýBoucher,ÌýMD
University of Minnesota
Minneapolis,ÌýMN
General Session 3: Incorporating Health Equity Education in UME/GME Curriculum

BeverlyÌýSchaefer,ÌýMD
University of Buffalo
Buffalo,ÌýNY
Breakout 1: Challenges of Course Development

Ariela L.ÌýMarshall,ÌýMD
University of Minnesota
¸é´Ç³¦³ó±ð²õ³Ù±ð°ù,Ìý²Ñ±·
Breakout 2: Developing Your Teaching Portfolio

Jason AÌýFreed,ÌýMD
Beth Israel Deaconess
µþ´Ç²õ³Ù´Ç²Ô,Ìý²Ñ´¡
Breakout 3: Cutting-Edge Technology in Education Delivery

Thomas W.ÌýLeBlanc,ÌýMD, MA, MSH
Duke Cancer Center
Durham,ÌýNC
Breakout 4: Developing a Palliative Care/Difficult Discussion Curriculum

back to top

Race and Ancestry in Precision Medicine

Race and ancestry, historically, have been poorly considered in basic and translational research design and clinical diagnoses. This session will describe how race and ancestry can inform hematology research conduct, specifically in clinical and genetic population profiling, interpretation of common hematologic tests, development of diagnostics, and overall precision medicine. The speakers selected in this session have incorporated race and ancestry in their own research and will be sharing their insights to help educate hematology investigators and clinicians understand how to consider race and ancestry into their own research and practice.

Co-Chairs:

Jennifer J.ÌýTrowbridge,ÌýPhD
The Jackson Laboratory
Bar Harbor,ÌýME

Sant-RaynÌýPasricha,ÌýMD,PhD
Walter and Eliza Hall Institute of Medical Research
Fitzroy North,ÌýVIC,ÌýAustralia

Speakers:

KeoluÌýFox
University of California, San Diego
San Diego,ÌýCA
Incorporating Indigenous Perspectives into Population Genetics

Ann-KathrinÌýEisfeld,ÌýMD
The Ohio State University Comprehensive Cancer Center
°ä´Ç±ô³Ü³¾²ú³Ü²õ,Ìý°¿±á
Risk Re-Stratification Based on Black AML Patient Exome Data

MaureenÌýAchebe
Brigham and Women's Hospital
µþ´Ç²õ³Ù´Ç²Ô,Ìý²Ñ´¡
How Inappropriate Reference Ranges Can Propagate Systemic Racism

back to top

Sickle Cell Disease Centers Session

The Role of Quality Metrics in Demonstrating Value of Your Sickle Cell Disease Center

To ensure high-quality care for patients with sickle cell disease (SCD), it is imperative that providers and SCD care leaders have the tools to establish comprehensive clinical care centers for patients with SCD. Over the last several years, ASH has developed a program and blueprint for the creation of sickle cell disease centers. This special interest session is designed to help sickle cell disease care centers understand the development of ÌýCMS quality metrics and how to leverage these metrics Ìýto support delivery of Ìýhigh quality care.

Co-Chairs:

SophieÌýLanzkron,ÌýMD
Sidney Kimmel College of Medicine, Thomas Jefferson University
±Ê³ó¾±±ô²¹»å±ð±ô±è³ó¾±²¹,Ìý±Ê´¡

CeceliaÌýCalhoun,ÌýMD,MBA,MPH
Yale New Haven Hospital
New Haven,ÌýCT

Speakers:

TitilopeÌýFasipe,ÌýMD,PhD
Texas Children's Cancer and Hematology Centers
±á´Ç³Ü²õ³Ù´Ç²Ô,Ìý°Õ³Ý
The Importance of Recognition of Pediatric Quality Metrics in SCD: The Role of US News and World Report

AlexandraÌýPower-Hays,ÌýMD
Cincinnati Children's Hospital
Cincinnati,ÌýOH
Will the Creation of CMS Quality Metrics Change Care in the Treatment of Painful Episodes in the Emergency Department?

CeceliaÌýCalhoun,ÌýMD,MBA,MPH
Yale New Haven Hospital
New Haven,ÌýCT
Leveraging Quality Metrics to Maintain Support of Your Sickle Cell Disease Center

back to top

Symposium for Mid-Career Hematologists

This symposium aims to guide the audience through the common challenges faced by mid-career hematologists. Some examples of unique challenges for mid-career hematologists include negotiating the first leadership position, principles of leadership, promotion, strategies for managing individuals and teams, conflict management, setting up a successful research program, time management, funding beyond career development awards, performance and compensation metrics, self-care and opportunities to contribute to the Society’s mission. Speakers will include a diverse pool of successful physicians and scientists from academia, regulatory agencies, and the pharmaceutical industry. It is envisioned that this educational session will be organized by a steering committee of Society members who will identify a longitudinal curriculum for the session and speakers and topics.

Chairs:

Juan PabloÌýAlderuccio,ÌýMD
Sylvester Comprehensive Cancer Center University of Miami
Miami,ÌýFL

ShrutiÌýChaturvedi,ÌýMBBS
Johns Hopkins University
Baltimore,ÌýMD

Speakers:

Ruben A.ÌýMesa,ÌýMD
Atrium Health Wake Forest Baptist
Winston-Salem,ÌýNC
Negotiating Your First Leadership Position

Allison A.ÌýKing,ÌýMD,PhD,MPH
Washington University School of Medicine
Saint Louis,ÌýMO
Negotiating Your First Leadership Position

Robert F.ÌýSidonio, Jr.,ÌýMD, MSc
Emory University
Atlanta,ÌýGA
Your Next Job - How to Identify Academic Opportunities with the Best Payback

Jeffrey DÌýLebensburger,ÌýDO
University of Alabama at Birmingham
µþ¾±°ù³¾¾±²Ô²µ³ó²¹³¾,Ìý´¡³¢
Your Next Job - How to Identify Academic Opportunities with the Best Payback

NinaÌýShah,ÌýMD
AstraZeneca
South San Francisco,ÌýCA
Making the Jump - Careers Outside Academia

David P.ÌýSteensma,ÌýMD, FACP
Ajax Therapeutics
Lincoln,ÌýMA
Making the Jump - Careers Outside Academia

back to top

Symposium on Quality: Treating Fairly - The Role of Quality Improvement in Combating Health Care Disparities

This year's Quality Symposium will focus on practical strategies for combatting healthcare disparities. First, Dr. Melissa Creary will discuss the Michigan Social Health Interventions to Eliminate Disparities (MSHIELD) program, a statewide data-driven, community-partnered, and equity-centered quality improvement effort. Then Dr. Michelle Sholzberg will review the development and impact of the "Raise the Bar" project, which aims to eliminate disparities in the recognition and management of iron deficiency by adjusting reference ranges. The session will conclude with a talk by Dr. Thomas Greg Knight on mitigating the impact of financial toxicity in patients with hematologic malignancies.

Co-Chairs:

Angela CÌýWeyand,ÌýMD
University of Michigan
Ann Arbor,ÌýMI

AdamÌýCuker,ÌýMD, MS
University of Pennsylvania
±Ê³ó¾±±ô²¹»å±ð±ô±è³ó¾±²¹,Ìý±Ê´¡

Speakers:

MelissaÌýCreary
University of Michigan School of Public Health
Ann Arbor,ÌýMI
MSHIELD - Michigan Social Health Interventions to Eliminate Disparities

MichelleÌýSholzberg,ÌýMDCM, MSc
University of Toronto
°Õ´Ç°ù´Ç²Ô³Ù´Ç,Ìý°¿±·,Ìý°ä²¹²Ô²¹»å²¹
Raise the Bar - Combatting Disparities in the Recognition and Management of Iron Deficiency

Thomas G.ÌýKnight,ÌýMD
Atrium Health
Charlotte,ÌýNC
Cancer and Poverty - Mitigating the Impact of Financial Toxicity in Patients with Hematologic Malignancies

back to top

Systems-Based Hematology Education and Networking Session: Anticoagulation Stewardship and AI-Assisted Management

This session will feature two talks on systems-level approaches to anticoagulation management, followed by a networking session where attendees will meet with the speakers and with established systems-based hematologists over light hors d'oeuvres and drinks. The first talk with feature Dr. Greg Barnes discussing how to improve systems-level management of anticoagulants within and across care settings. For the second talk, Dr. Damon E. Houghton will discuss the use of artificial intelligence (AI) and machine learning (ML) in the context of anticoagulation management.

Chair:

CamilaÌýMasias,ÌýMD,MPH
Miami Cancer Institute
Miami,ÌýFL

Speakers:

Geoffrey DÌýBarnes,ÌýMD, MSc
University of Michigan
Ann Arbor,ÌýMI
Improving Systems-Level Management of Anticoagulants Within and Across Care Settings

Damon E.ÌýHoughton,ÌýMD,MS
Mayo Clinic Rochester
¸é´Ç³¦³ó±ð²õ³Ù±ð°ù,Ìý²Ñ±·
Artificial Intelligence (AI) and Machine Learning (ML) in the Context of Anticoagulation Management

back to top

Training Program Directors Workshop

The Training Program Director’s Workshop is held each year before the ASH annual meeting and is designed for training program directors, associate program directors, and others involved with hematology training. The workshop is designed for hematology program directors to share lessons learned, best practice, and explore opportunities to improve their leadership skills. Through experiential learning techniques, breakout sessions, and interactive lectures, program directors can learn from peers and build their network. At this year’s TPDW, we will focus on three opportune topics. First, we will discuss how to design and implement innovative curriculums which can prepare trainees to excel at various aspects of hematology oncology practice beyond just knowledge of the subject matter. Examples of such curriculums include ‘leadership training’, ‘how to be a good educator’, and ‘business of hematology-oncology’. Second, we will focus on best practices for a training program to leverage social media and build their ‘brand’. Lastly, we will discuss practical ways in which programs can help trainees land their dream job.

Chair:

PallawiÌýTorka
Roswell Park Cancer Center
Buffalo,ÌýNY

Speakers:

ScottÌýMoerdler,ÌýMD
Rutgers Cancer Institute
New Brunswick,ÌýNJ
Innovative Fellowship Curriculum

Layla NÌýVan Doren,ÌýMD, MBA
Yale School of Medicine
New Haven,ÌýCT
Innovative Fellowship Curriculum

Angela CÌýWeyand,ÌýMD
University of Michigan
Ann Arbor,ÌýMI
Leveraging and Enriching Social Media

GeraldÌýHsu,ÌýMD,PhD
University of California, San Francisco
San Francisco,ÌýCA
Best Practices to Support Fellows in the Job Search

SunandanaÌýChandra,ÌýMD
Northwestern University
°ä³ó¾±³¦²¹²µ´Ç,Ìý±õ³¢
Best Practices to Support Fellows in the Job Search

back to top

Women In Hematology Networking Event (for in-person participants)

This popular annual reception will provide a space where all can gather in an informal environment and connect with peers and potential mentors. The event will include a panel discussion focused on leadership through a gender and career development lens as well as ample networking opportunities.

Moderators:

BethanyÌýSamuelson Bannow,ÌýMD
Oregon Health and Science University
Portland,ÌýOR

GlaivyÌýBatsuli,ÌýMD
Stanford University
³§³Ù²¹²Ô´Ú´Ç°ù»å,Ìý°ä´¡

Speakers:

NinaÌýBalanchivadze,ÌýMD
Virginia Oncology Associates
Norfolk,ÌýVA

OyebimpeÌýAdesina,ÌýMD,MS
UC Davis Comprehensive Cancer Center
SACRAMENTO,ÌýCA

AlisonÌýLoren,ÌýMD
University of Pennsylvania
±Ê³ó¾±±ô²¹»å±ð±ô±è³ó¾±²¹,Ìý±Ê´¡